BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7062945)

  • 61. Pulmonary lymphangioleiomyomatosis.
    Reich JM
    Chest; 1992 Sep; 102(3):984. PubMed ID: 1516449
    [No Abstract]   [Full Text] [Related]  

  • 62. Introduction to lymphoproliferative disorders in adults.
    Leclair SJ; Ferreira K
    Clin Lab Sci; 2013; 26(4):181. PubMed ID: 24432510
    [No Abstract]   [Full Text] [Related]  

  • 63. Treatment of lymphangioleiomyomatosis.
    N Engl J Med; 1991 Jul; 325(1):63-4. PubMed ID: 2046715
    [No Abstract]   [Full Text] [Related]  

  • 64. Lymphangioleiomyomatosis and pregnancy: a mini-review.
    Zhou J; Diao M
    Arch Gynecol Obstet; 2024 Jun; 309(6):2339-2346. PubMed ID: 38594407
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience.
    Revilla-López E; Berastegui C; Méndez A; Sáez-Giménez B; Ruiz de Miguel V; López-Meseguer M; Monforte V; Bravo C; Pujana MA; Ramon MA; Gómez-Ollés S; Roman A;
    Sci Rep; 2021 May; 11(1):10171. PubMed ID: 33986388
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis.
    Wang Q; Luo M; Xiang B; Chen S; Ji Y
    Respir Res; 2020 Feb; 21(1):55. PubMed ID: 32059669
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.
    McCormack FX; Gupta N; Finlay GR; Young LR; Taveira-DaSilva AM; Glasgow CG; Steagall WK; Johnson SR; Sahn SA; Ryu JH; Strange C; Seyama K; Sullivan EJ; Kotloff RM; Downey GP; Chapman JT; Han MK; D'Armiento JM; Inoue Y; Henske EP; Bissler JJ; Colby TV; Kinder BW; Wikenheiser-Brokamp KA; Brown KK; Cordier JF; Meyer C; Cottin V; Brozek JL; Smith K; Wilson KC; Moss J;
    Am J Respir Crit Care Med; 2016 Sep; 194(6):748-61. PubMed ID: 27628078
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis.
    Contini P; Schiavina M; Schiavina R; Tavalazzi F; Fabiani A; Di Scioscio V; Spagnolo P; Richeldi L
    Multidiscip Respir Med; 2011 Oct; 6(5):313-7. PubMed ID: 22958860
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans.
    Juvet SC; McCormack FX; Kwiatkowski DJ; Downey GP
    Am J Respir Cell Mol Biol; 2007 Apr; 36(4):398-408. PubMed ID: 17099139
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study.
    Wahedna I; Cooper S; Williams J; Paterson IC; Britton JR; Tattersfield AE
    Thorax; 1994 Sep; 49(9):910-4. PubMed ID: 7940433
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tuberous sclerosis with pulmonary involvement.
    Liberman BA; Chamberlain DW; Goldstein RS
    Can Med Assoc J; 1984 Feb; 130(3):287-9. PubMed ID: 6692213
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pulmonary tuberous sclerosis treated with tamoxifen and progesterone.
    Westermann CJ; Oostveen AC; Wagenaar SS; Hilvering C; Overbeek SE; Verheijen-Breemhaar D; Corrin B
    Thorax; 1986 Nov; 41(11):892-3. PubMed ID: 3824277
    [No Abstract]   [Full Text] [Related]  

  • 73. Lymphangiomyomatosis: a report of three cases treated with tamoxifen.
    Clemm C; Jehn U; Wolf-Hornung B; Siemon G; Walter G
    Klin Wochenschr; 1987 Apr; 65(8):391-3. PubMed ID: 3586575
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lymphangiomyomatosis: a respiratory illness with an endocrinologic therapy.
    Sieker HO; McCarty KS
    Trans Am Clin Climatol Assoc; 1988; 99():57-67. PubMed ID: 3503438
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tamoxifen for lymphangioleiomyomatosis.
    Tomasian A; Greenberg MS; Rumerman H
    N Engl J Med; 1982 Mar; 306(12):745-6. PubMed ID: 7062945
    [No Abstract]   [Full Text] [Related]  

  • 76. [Case report on the hormonal aspects of the therapy of pulmonary lymphangioleiomyomatosis].
    Bettendorf U; Bauer KH; Kaiser E
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():1024-5. PubMed ID: 6647245
    [No Abstract]   [Full Text] [Related]  

  • 77. Lymphangioleiomyomatosis: treatment with hormonal manipulation.
    Brock ET; Votto JJ
    N Y State J Med; 1986 Oct; 86(10):533-6. PubMed ID: 3466061
    [No Abstract]   [Full Text] [Related]  

  • 78. [A case of pulmonary lymphangiomyomatosis with tuberous sclerosis--treated with tamoxifen].
    Hara H; Tono Y; Matsushima T; Manabe T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Aug; 25(8):918-23. PubMed ID: 3694971
    [No Abstract]   [Full Text] [Related]  

  • 79. [2 cases of lymphangioleiomyomatosis treated by hormonal manipulation].
    Anker N; Francis D; Viskum K
    Ugeskr Laeger; 1993 Jul; 155(30):2354-6. PubMed ID: 8346582
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Successful treatment of pulmonary lymphangioleiomyomatosis with oophorectomy and medroxyprogesterone-acetate: report of a case and brief review of the literature.
    van Milligen de Wit AW; Meilof-Planteydt MN
    Neth J Med; 1990 Jun; 36(5-6):246-51. PubMed ID: 2203977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.